Skip to main content

. 1980 Nov 1;281(6249):1178. doi: 10.1136/bmj.281.6249.1178

Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster.

E de Clercq, H Degreef, J Wildiers, G de Jonge, A Drochmans, J Descamps, P de Somer

PMCID: PMC1714507 PMID: 7427624

1178

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

De Clercq E., Descamps J., De Somer P., Barr P. J., Jones A. S., Walker R. T. (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent. Proc Natl Acad Sci U S A. 1979 Jun;76(6):2947–2951. doi: 10.1073/pnas.76.6.2947. [DOI] [PMC free article] [PubMed] [Google Scholar]
Maudgal P. C., De Clercq E., Descamps J., Missotten L., De Somer P., Busson R., Vanderhaeghe H., Verhelst G., Walker R. T., Jones A. S. (E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis. Antimicrob Agents Chemother. 1980 Jan;17(1):8–12. doi: 10.1128/aac.17.1.8. [DOI] [PMC free article] [PubMed] [Google Scholar]
Selby P. J., Powles R. L., Janeson B., Kay H. E., Watson J. G., Thornton R., Morgenstern G., Clink H. M., McElwain T. J., Prentice H. G. Parenteral acyclovir therapy for herpesvirus infections in man. Lancet. 1979 Dec 15;2(8155):1267–1270. doi: 10.1016/s0140-6736(79)92281-5. [DOI] [PubMed] [Google Scholar]
de Clercq E., Descamps J., de Somer P., Barr P. J., Jones A. S., Walker R. T. Pharmacokinetics of E-5-(2-bromovinyl)-2'-deoxyuridine in mice. Antimicrob Agents Chemother. 1979 Aug;16(2):234–236. doi: 10.1128/aac.16.2.234. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES